...Gerard A. Kalkman; Wim van den Brink; Mimi Pierce; Femke Atsma; Kris C. P. Vissers; Henk J. Schers; Robert T. M. van Dongen; Cornelis Kramers; Arnt F. A. Schellekens The past 20 years, the USA is facing a serious opioid crisis initiated by an increase in prescription opioid use. Europe has also...

...Pol Rovira; Carolin Kilian; Maria Neufeld; Harriet Rumgay; Isabelle Soerjomataram; Carina Ferreira-Borges; Kevin D. Shield; Bundit Sornpaisarn; Jürgen Rehm Introduction: Prevention of cancer has been identified as a major public health priority for Europe, and alcohol is a leading risk factor...

...) is the most prevalent cannabis-based medicinal product marketed in Europe. Synthetic cannabinoids and standardized cannabis are less prevalent, and no country allows the growing of cannabis for personal medical use. The bringing of medical cannabis products from across borders to countries where the drug...

... Europe Joinpoint regression The cannabis clients entering treatment for the first time in 2014 spent 2 years longer outside treatment than their equivalents in 2003, and were on average 2 years older (25 vs. 23) when they entered treatment, although starting cannabis use at the same age [ 16...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Opioid maintenance treatment Europe Opioid use disorder Around...

.... The 1-year prevalence of AD in the EU was estimated at 3.4% among people 18-64 years of age in Europe (women 1.7%, men 5.2%), resulting in close to 11 million affected people. Taking into account all people of all ages, AD, abuse and harmful use resulted in an estimate of 23 million affected people...

...% of acceptance by European experts and stakeholders. Conclusion: A high consensus of European MQS for treatment/rehabilitation and harm reduction has been achieved. Further implementation and developmental steps are discussed. Quality Standards Treatment Rehabilitation Harm reduction Europe 4 12...

...Magnus Israelsson Aims: The study explores the existence and types of law on compulsory commitment to care (CCC) of adult substance misusers in Europe and how such laws are related to variations in demographics, alcohol consumption and epidemiology in misuse of opiates, cocaine, amphetamines...

...Witold A. Zatoński; Urszula Sulkowska; Marta Mańczuk; Jürgen Rehm; Paolo Boffetta; Albert B. Lowenfels; Carlo La Vecchia Background and Aims: Over the last decades, Europe has experienced dramatic changes in the geographical variation of liver cirrhosis rates. We attempt to provide a comprehensive...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Women Drugs HIV Services Europe...

... to in the content or advertisements. Alcohol Gender, Alcohol and Culture: An International Study (GENACIS) Europe Binge drinking Heavy episodic drinking Drinking pattern Alcohol-related consequences European Addiction Research Research Report Eur Addict Res 2008;14:71 81 DOI: 10.1159/000113721...

..., in line with the profile and needs of the patient in each context. 9 12 2005 Injecting drug use Risk behavior Europe European Addiction Research Research Report Eur Addict Res 2006;12:33 41 DOI: 10.1159/000088581 Drugs and Social Exclusion in Ten European Cities Joan Carles March Eugenia...

...Jürgen Rehm; Gerhard Gmel; Robin Room; Ulrich Frick Objective: To determine the burden of mortality in young people (age 15–29) in established market economies in Europe in 1999, which is attributable to alcohol consumption. Two dimensions of alcohol consumption were considered: average volume...